{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:43:59Z","timestamp":1777995839437,"version":"3.51.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023280","name":"CSL Seqirus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The mammalian cell-based quadrivalent inactivated influenza vaccine (IIV4c) has advantages over egg-based quadrivalent inactivated influenza vaccine (IIV4e), as production using cell-derived candidate viruses eliminates the opportunity for egg adaptation. This study estimated the relative vaccine effectiveness (rVE) of IIV4c versus IIV4e in preventing cardiorespiratory hospitalizations during the 2019\u20132020 US influenza season.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study using electronic medical records linked to claims data of US individuals aged 18\u201364 years. We assessed rVE against cardiorespiratory hospitalizations and against subcategories of this outcome, including influenza, pneumonia, myocardial infarction and ischemic stroke, and respiratory hospitalizations. We used a doubly robust inverse probability of treatment weighting and logistic regression model to obtain odds ratios (ORs; odds of outcome among IIV4c recipients\/odds of outcome among IIV4e recipients) adjusted for age, sex, race, ethnicity, geographic region, vaccination week, health status, frailty, and healthcare resource utilization. rVE was calculated as 100(1 \u2212 ORadjusted).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 1 491 097 individuals (25.2%) received IIV4c, and 4 414 758 (74.8%) received IIV4e. IIV4c was associated with lower odds of cardiorespiratory (rVE, 2.5% [95% confidence interval, 0.9%\u20134.1%]), respiratory (3.7% [1.5%\u20135.8%]), and influenza (9.3% [0.4%\u201317.3%]) hospitalizations among adults 18\u201364 years of age. No difference was observed for the other outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This real-world study conducted for the 2019\u20132020 season demonstrated that vaccination with IIV4c was associated with fewer cardiorespiratory, respiratory, and influenza hospitalizations compared with IIV4e.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad304","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T16:59:20Z","timestamp":1686329960000},"source":"Crossref","is-referenced-by-count":3,"title":["Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18\u201364 Years During the 2019\u20132020 US Influenza Season"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-0182","authenticated-orcid":false,"given":"Mahrukh","family":"Imran","sequence":"first","affiliation":[{"name":"CSL Seqirus , Kirkland, Quebec , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Puig-Barbera","sequence":"additional","affiliation":[{"name":"FISABIO , Valencia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin R","family":"Ortiz","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Lopez-Gonzalez","sequence":"additional","affiliation":[{"name":"Veradigm , Chicago, Illinois , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Dean","sequence":"additional","affiliation":[{"name":"Veradigm , Chicago, Illinois , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machaon","family":"Bonafede","sequence":"additional","affiliation":[{"name":"Veradigm , Chicago, Illinois , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mendel","family":"Haag","sequence":"additional","affiliation":[{"name":"CSL Seqirus Netherlands B.V. , Amsterdam , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"2023072516252428100_ofad304-B1","author":"Centers for Disease Control and Prevention."},{"key":"2023072516252428100_ofad304-B2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamacardio.2016.0433","article-title":"Seasonal influenza infections and cardiovascular disease mortality","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2023072516252428100_ofad304-B3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/irv.12470","article-title":"The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection","volume":"11","author":"Sellers","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"2023072516252428100_ofad304-B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","article-title":"Role of acute infection in triggering acute coronary syndromes","volume":"10","author":"Corrales-Medina","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2023072516252428100_ofad304-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2020\u201321 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2023072516252428100_ofad304-B6","author":"Rajaram"},{"key":"2023072516252428100_ofad304-B7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0042-6822(87)90418-1","article-title":"Host cell-mediated variation in H3N2 influenza viruses","volume":"156","author":"Katz","year":"1987","journal-title":"Virology"},{"issue":"pt 11","key":"2023072516252428100_ofad304-B8","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1099\/0022-1317-74-11-2513","article-title":"Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses","volume":"74","author":"Rocha","year":"1993","journal-title":"J Gen Virol"},{"key":"2023072516252428100_ofad304-B9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/infdis\/jiy716","article-title":"Relative effectiveness of cell-cultured and egg-based influenza vaccines among elderly persons in the United States, 2017\u20132018","volume":"220","author":"Izurieta","year":"2019","journal-title":"J Infect Dis"},{"key":"2023072516252428100_ofad304-B10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41541-018-0079-z","article-title":"Cell culture-derived influenza vaccines in the severe 2017\u20132018 epidemic season: a step towards improved influenza vaccine effectiveness","volume":"3","author":"Barr","year":"2018","journal-title":"NPJ Vaccines"},{"key":"2023072516252428100_ofad304-B11","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1093\/cid\/ciaa371","article-title":"Relative effectiveness of the cell-cultured quadrivalent influenza vaccine compared to standard, egg-derived quadrivalent influenza vaccines in preventing influenza-like illness in 2017\u20132018","volume":"71","author":"Boikos","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023072516252428100_ofad304-B12","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.1093\/cid\/ciaa1944","article-title":"Relative effectiveness of the cell-derived inactivated quadrivalent influenza vaccine versus egg-derived inactivated quadrivalent influenza vaccines in preventing influenza-related medical encounters during the 2018\u20132019 influenza season in the United States","volume":"73","author":"Boikos","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023072516252428100_ofad304-B13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/INF.0000000000003620","article-title":"Relative effectiveness of cell-based versus egg-based quadrivalent influenza vaccines in children and adolescents in the United States during the 2019\u20132020 influenza season","volume":"41","author":"Imran","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"2023072516252428100_ofad304-B14","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab167","article-title":"Effectiveness of the cell-derived inactivated quadrivalent influenza vaccine in individuals at high risk of influenza complications in the 2018\u20132019 United States influenza season","volume":"8","author":"Boikos","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2023072516252428100_ofad304-B15","article-title":"Relative effectiveness of cell-based versus egg-based quadrivalent influenza vaccines in adults during the 2019\u20132020 influenza season in the United States","volume":"9","author":"Imran","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2023072516252428100_ofad304-B16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab604","article-title":"A real-world clinical and economic analysis of cell-derived quadrivalent influenza vaccine compared to standard egg-derived quadrivalent influenza vaccines during the 2019\u20132020 influenza season in the United States","volume":"9","author":"Divino","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2023072516252428100_ofad304-B17","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1016\/j.vaccine.2020.07.023","article-title":"A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017\u201318 influenza season","volume":"38","author":"Divino","year":"2020","journal-title":"Vaccine"},{"key":"2023072516252428100_ofad304-B18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/vaccines9020080","article-title":"Clinical and economic outcomes associated with cell-based quadrivalent influenza vaccine vs. standard-dose egg-based quadrivalent influenza vaccines during the 2018\u201319 influenza season in the United States","volume":"9","author":"Krishnarajah","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2023072516252428100_ofad304-B19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/cid\/ciab1016","article-title":"Interpretation of relative efficacy and effectiveness for influenza vaccines","volume":"75","author":"Lewis","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023072516252428100_ofad304-B20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"2023072516252428100_ofad304-B21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"2023072516252428100_ofad304-B22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/vaccines10050727","article-title":"Integrating electronic medical records and claims data for influenza vaccine research","volume":"10","author":"Boikos","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2023072516252428100_ofad304-B23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s40471-020-00243-4","article-title":"A selective review of negative control methods in epidemiology","volume":"7","author":"Shi","year":"2020","journal-title":"Curr Epidemiol Rep"},{"key":"2023072516252428100_ofad304-B24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"2023072516252428100_ofad304-B25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2023072516252428100_ofad304-B26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"2023072516252428100_ofad304-B27","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"2023072516252428100_ofad304-B28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwq439","article-title":"Doubly robust estimation of causal effects","volume":"173","author":"Funk","year":"2011","journal-title":"Am J Epidemiol"},{"key":"2023072516252428100_ofad304-B29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1750-2659.2012.00422.x","article-title":"Influenza surveillance in Europe: establishing epidemic thresholds by the moving epidemic method","volume":"7","author":"Vega","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"2023072516252428100_ofad304-B30","author":"Centers for Disease Control and Prevention."},{"key":"2023072516252428100_ofad304-B31","author":"Centers for Disease Control and Prevention."},{"key":"2023072516252428100_ofad304-B32","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/infdis\/jiy717","article-title":"Comparing influenza vaccine types: the path toward improved influenza vaccine strategies","volume":"220","author":"Flannery","year":"2019","journal-title":"J Infect Dis"},{"key":"2023072516252428100_ofad304-B33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/cid\/ciz416","article-title":"Improving influenza vaccine effectiveness: ways to begin solving the problem","volume":"69","author":"Monto","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023072516252428100_ofad304-B34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/infdis\/jiz543","article-title":"Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018\u20132019 season","volume":"221","author":"Flannery","year":"2020","journal-title":"J Infect Dis"},{"key":"2023072516252428100_ofad304-B35","article-title":"Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing","volume":"8","author":"Rajaram","year":"2020","journal-title":"Ther Adv Vaccines Immunother"},{"key":"2023072516252428100_ofad304-B36","author":"World Health Organization."},{"key":"2023072516252428100_ofad304-B37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.15585\/mmwr.mm6907a1","article-title":"Interim estimates of 2019\u201320 seasonal influenza vaccine effectiveness\u2014United States, February 2020","volume":"69","author":"Dawood","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023072516252428100_ofad304-B38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.15585\/mmwr.mm6840a3","article-title":"Update: influenza activity\u2014United States and worldwide, May 19-September 28, 2019, and composition of the 2020 southern hemisphere influenza vaccine","volume":"68","author":"Epperson","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023072516252428100_ofad304-B39","author":"Food and Drug Administration, Center for Biologics Evaluation and Research."},{"key":"2023072516252428100_ofad304-B40","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiz049","article-title":"Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017\u20132018 influenza season","volume":"219","author":"Levine","year":"2019","journal-title":"J Infect Dis"},{"key":"2023072516252428100_ofad304-B41","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad304\/50526216\/ofad304.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/7\/ofad304\/50958952\/ofad304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/7\/ofad304\/50958952\/ofad304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T16:26:36Z","timestamp":1690302396000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad304\/7191281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad304","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,6,7]]},"article-number":"ofad304"}}